CLASS II Drug recall · Reported 22 Jan 2014 · FDA Enforcement Report

Nifedipine, extended-release tablets, 90mg recalled by Greenstone

Greenstone is recalling Nifedipine, extended-release tablets, 90mg, distributed nationwide in the US. The recall was initiated on 1 Nov 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesV110079

Quantity recalled21600 tablets

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-737-2014
FDA event ID: 66760
Recalling firm: Greenstone, Peapack, NJ
Classification: Class II
Status: Terminated
Recall initiated: 1 Nov 2013
FDA classified: 16 Jan 2014
Reported: 22 Jan 2014
Type: Voluntary: Firm initiated
Customers notified by: Telephone
Reason category: Packaging Defects
Drug class: Blood Pressure Medication

Timeline

1 Nov 2013	Recall initiated by company
16 Jan 2014	Classified by FDA	+76 days
22 Jan 2014	Published in enforcement report	+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Greenstone LLC is recalling Nifedipine Extended Release tablets (90mg). The expiration date on the package is 48 months instead of 36 months.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Nifedipine, extended-release tablets, 90mg 100 count blister pack, Rx only, Distributed by: GREENSTONE LLC, Pespack, NJ,07977, NDC 59762-6692-8

Where it was distributed

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Incorrect or Missing Lot and/or Exp Date: Greenstone LLC is recalling Nifedipine Extended Release tablets (90mg). The expiration date on the package is 48 months instead of 36 months.

Which lots are affected?

V110079

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Greenstone

All 7

Reported	Class	Recall	Company	Reason	Where
4 Feb 2026Drug	CLASS II	methylprednisolone tablets, USP Dosepak, 4 mg recalled by GreenstoneMethylprednisolone	Greenstone	Other	Nationwide
18 Jun 2014Drug	CLASS I	Venlafaxine HCl Extended-Release Capsules, 150 mg Unit of Use recalled	Greenstone	Packaging Defects	Nationwide
12 Feb 2014Drug	CLASS III	Glipizide XL (glipizide) extended release tablets, 5 mg recalled	Greenstone	Potency & Assay	Nationwide
29 Jan 2014Drug	CLASS II	sertraline HCl tablets, 25 mg recalled by Greenstone	Greenstone	Other	Nationwide
27 Nov 2013Drug	CLASS II	Spironolactone tablets, USP 50 mg recalled by Greenstone	Greenstone	Potency & Assay	Nationwide

Other Nifedipine recalls

All 10

Reported	Class	Recall	Company	Reason	Where
21 Jul 2021Drug	CLASS II	NIFEdipine Extended-release Tablets, USP 30 mg recalledNifedipine	The Harvard Drug Group	Potency & Assay	NJ, OH
12 Apr 2017Drug	CLASS III	Nifedipine Extended-Release Tablets, 30 mg recalled by Alvogen	Alvogen	Other	Nationwide
12 Apr 2017Drug	CLASS III	Nifedipine Extended-Release Tablets, 60 mg recalled by Alvogen	Alvogen	Other	Nationwide
12 Apr 2017Drug	CLASS III	Nifedipine Extended-Release Tablets, 90 mg recalled by Alvogen	Alvogen	Other	Nationwide
30 Nov 2016Drug	CLASS III	NIFEdipine Capsules USP, 10 mg recalled by Actavis Elizabeth	Actavis Elizabeth	Other	NJ